PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Division, Leumit Health Services, Tel-Aviv, Israel.\', \'Department of Family Medicine, Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.\', \'Leumit Health Services, Central District Headquarter, Netanya, Israel.\', \'The Pesach Segal Israeli Center for Diabetes Research and Policy, Sheba Medical Center, Ramat Gan, Israel.\', \'Diabetes Medical Center, Tel Aviv, Israel.\', \'Diabetes Unit, Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.\', \'Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/dmrr.3398
?:hasPublicationType
?:journal
  • Diabetes/metabolism research and reviews
is ?:pmid of
?:pmid
?:pmid
  • 32852883
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.807
?:rankingScore_hIndex
  • 97
is ?:relation_isRelatedTo_publication of
?:title
  • Haemoglobin A1c is a predictor of COVID-19 severity in patients with diabetes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all